Ras as a target in cancer therapy
- 22 June 2002
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 44 (2) , 109-120
- https://doi.org/10.1016/s1040-8428(01)00189-5
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Ras protein signallingSeminars in Immunology, 2000
- Persistence, Immune Specificity, and Functional Ability of Murine Mutant Ras Epitope-Specific CD4+ and CD8+ T Lymphocytes Following in Vivo Adoptive TransferCellular Immunology, 1999
- Identification of a Human CD8+T Lymphocyte Neo-epitope Created by arasCodon 12 Mutation Which Is Restricted by the HLA-A2 AlleleCellular Immunology, 1998
- Ras-GRF Activates Ha-Ras, but Not N-Ras or K-Ras 4B, Proteinin VivoPublished by Elsevier ,1998
- G PROTEIN MECHANISMS: Insights from Structural AnalysisAnnual Review of Biochemistry, 1997
- Receptor-tyrosine-kinase- and Gβγ-mediated MAP kinase activation by a common signalling pathwayNature, 1995
- Proteins regulating Ras and its relativesNature, 1993
- Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1Nature, 1993
- The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1Nature, 1993
- Isolation of a transforming sequence from a human bladder carcinoma cell lineCell, 1982